Recurrent ischemic stroke in a case of Takayasu’s arteritis, mimicking multiple sclerosis

Sasannejad, Payam; Verdipour, Mahdieh; Asadi, Mona; Ahmadi, Hamideh

doi:10.18502/ijnl.v18i3.1639

Cited by 1 publication

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Life 2022, 12,1904 from France reported ischemic stroke or TIA in 15.9% of their TAK patients [48]. Some other cohorts of TAK patients have reported stroke less frequently.…”

Section: Stroke At Presentation and On Follow-up In Tak Patientsmentioning

confidence: 99%

See 1 more Smart Citation

Comparison of Presentation and Prognosis of Takayasu Arteritis with or without Stroke or Transient Ischemic Attack—A Retrospective Cohort Study

Misra

Rathore

Mishra

et al. 2022

Life

View full text Add to dashboard Cite

Takayasu arteritis (TAK) could cause a stroke or transient ischemic attack (TIA) in young individuals due to inflammatory vascular occlusion or intracerebral hemorrhage. We compared the clinical presentation, angiographic features, longitudinal patterns of disease activity, medical treatments, and survival in 34 TAK patients with stroke/TIA and 157 without stroke/TIA from a single-center retrospective cohort. TAK patients with stroke/TIA were older (p = 0.044) with a greater proportion of males (p = 0.022), more frequent vision loss (odds ratio (OR) for stroke/TIA vs. without stroke TIA 5.21, 95% CI 1.42–19.14), and less frequent pulse or blood pressure inequality (OR 0.43, 95% CI 0.19–0.96) than TAK patients without stroke/TIA. Hata’s angiographic type IIa was more common in TAK patients with stroke/TIA (OR 11.00, 95%CI 2.60–46.58) and type V in TAK patients without stroke/TIA (OR 0.27, 95% CI 0.12–0.58). Cyclophosphamide was used more often in TAK patients with stroke/TIA (p = 0.018). Disease activity at baseline, 6, 12, and 24 months of follow-up was mostly similar for both groups. Risk of mortality was similar in TAK patients with or without stroke/TIA (hazard ratio unadjusted 0.76, 95% CI 0.15–3.99; adjusted for gender, age of disease onset, delay to diagnosis, baseline disease activity, and the number of conventional or biologic/targeted synthetic immunosuppressants used 1.38, 95% CI 0.19–10.20) even after propensity score-matched analyses. Stroke or TIA does not appear to affect survival in TAK patients adversely.

show abstract

“…Life 2022, 12,1904 from France reported ischemic stroke or TIA in 15.9% of their TAK patients [48]. Some other cohorts of TAK patients have reported stroke less frequently.…”

Section: Stroke At Presentation and On Follow-up In Tak Patientsmentioning

confidence: 99%

“…Up to one-third of TAK patients present with major ischemic events (including stroke) [7,10,11], even with normal acute-phase reactants [11]. Patients with TAK can have recurrent strokes [12]. Ischemic stroke in TAK patients can also occur following vascular procedures [13].…”

Section: Introductionmentioning

confidence: 99%

Comparison of Presentation and Prognosis of Takayasu Arteritis with or without Stroke or Transient Ischemic Attack—A Retrospective Cohort Study

Misra

Rathore

Mishra

et al. 2022

Life

View full text Add to dashboard Cite

show abstract

Recurrent ischemic stroke in a case of Takayasu’s arteritis, mimicking multiple sclerosis

Abstract: This article is a Letter to the Editor and does not include an Abstract.

Cited by 1 publication

References 4 publications

Comparison of Presentation and Prognosis of Takayasu Arteritis with or without Stroke or Transient Ischemic Attack—A Retrospective Cohort Study

Comparison of Presentation and Prognosis of Takayasu Arteritis with or without Stroke or Transient Ischemic Attack—A Retrospective Cohort Study

Contact Info

Product

Resources

About